Berry Plastics Group Inc has agreed to acquire AVINTIV from The Blackstone Group LP for about $2.45 billion. The deal is expected to be completed by the end of the year. Credit Suisse and Barclays provided financial advice to Berry Plastics on the transaction while Citi and BofA Merrill Lynch did likewise for AVINTIV and Blackstone. Headquartered in Charlotte, North Carolina, AVINTIV is a specialty materials provider used in infection prevention, personal care, and high-performance solutions.

Houlihan Lokey Inc. filed to raise as much as $100 million in an IPO, according to a July 10 SEC filing. The Los Angeles-based investment bank is backed by ORIX USA Corp. Houlihan Lokey did not list how many shares it would sell or their price range. That will come in future filings. Houlihan Lokey does plan to trade on the NYSE under the ticker symbol “HLI.” Bookrunners on the deal include BofA Merrill Lynch and Goldman, Sachs & Co.

Madison Dearborn Partners has agreed to buy Patterson Companies Inc‘s medical business Patterson Medical for about $715 million in cash. The transaction is expected to be completed in the fiscal second quarter. BofA Merrill Lynch served as financial advisor to Patterson Companies while Barclays and Deutsche Bank advised MDP.

GE said Tuesday that it has agreed to sell its European Sponsor Finance business to Sumitomo Mitsui Banking Corp. Europe Ltd., a subsidiary of Sumitomo Mitsui Banking Corp., for about $2.2 billion. The GE business provides sponsor finance for European mid-market private equity deals. GE Capital is keeping its $1 billion investment in the European Senior Secured Loan Programme and European Loan Programme, both joint ventures between GE Capital and Ares Capital. The deal is expected to close in third quarter. Bank of America Merrill Lynch and Citigroup Global Markets advised GE.

Lone Star Funds has agreed to acquire Home Properties Inc in a take-private deal valued at about $7.6 billion. The transaction is expected to be completed during the fourth quarter of this year. BofA Merrill Lynch served as financial advisor to Home Properties while Goldman Sachs.did likewise for Lone Star. Home Properties Inc owns, operates, acquires and repositions apartment communities in major metropolitan suburbs.

Vancouver-based ProNAi Therapeutics, a developer of nucleic acid therapeutics, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. The stock will list on the NASDAQ under the ticker symbol “DNAI.” Jefferies LLC and BofA Merrill Lynch will serve as the lead underwriters. ProNAi’s backers include Vivo Capital, Frazier Healthcare Ventures, OrbiMed Advisors, Adams Street Partners, RA Capital Management, Caxton Alternative Management, Hopen Life Science Ventures, Sectoral Asset Management and Janus Capital Management.

EndoChoice, an Atlanta area-based provider of endoscopy products and services, has debuted its IPO after pricing its 6.35 million shares at $15 per share. The stock began trading Friday on the NYSE under the ticker symbol “GI.” JP Morgan and BofA Merrill Lynch are the lead underwriters. EndoChoice’s backers include Council Capital and River Cities Capital Funds.

Vienna, Virginia-based Alarm.com Holdings, a connected home platform solution, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. The company plans on trading the stock on the NASDAQ under the ticker symbol “ALRM.” Goldman, Sachs & Co, Credit Suisse Securities LLC and BofA Merrill Lynch are serving as the lead underwriters. Alarm.com’s backers include ABS Capital and Technology Crossover Ventures.

Fortress Transportation and Infrastructure Investors LLC, which owns and acquires transportation-related infrastructure and equipment, has raised $34 million for its IPO after pricing its 20 million shares at $17 per share. The stock began trading Friday on the NYSE under the ticker symbol “FTAI.” Citigroup Global Markets Inc., BofA Merrill Lynch, Barclays Capital Inc, Deutsche Bank Securities Inc and UBS Securities LLC are the lead underwriters. FTAI is owned by Fortress Investment Group.

Laguna Hills, California-based Glaukos Corporation, a developer of treatments for glaucoma, has filed for an IPO. The number of shares that will be sold as well as the IPO’s pricing terms have yet to be set. The company plans on trading the stock on the NYSE under the ticker symbol “GKOS.” J.P. Morgan, BofA Merrill Lynch and Goldman, Sachs & Co are serving as the lead underwriters. Glaukos’ backers include OrbiMed Advisors, Frazier Healthcare Ventures, InterWest Partners, Domain Associates, Fjord Ventures, Montreaux Equity Partners and Versant Ventures

UK and Philadelphia-based biotechnology company Adaptimmune Therapeutics plc has debuted its IPO after pricing its 11.25 million shares at $17 per share. The stock began trading Wednesday on the NASDAQ under the ticker symbol “ADAP.” BofA Merrill Lynch, Cowen and Company and Leerink Partners LLC are serving as the lead underwriters. Adaptimmune’s backers include New Enterprise Associates, OrbiMed Advisors, Wellington Management Company, Fidelity Biosciences, Foresite Capital Management, Ridgeback Capital Management and Rock Springs Capital.

Restaurant chain Bojangles Inc will be selling 6.25 million shares of its IPO at between $15 and $17 per share. The company will list the stock on the NASDAQ under the ticker symbol “BOJA.” BofA Merrill Lynch, Wells Fargo Securities and Jefferies are serving as the lead underwriters. Bojangles is a portfolio company of Advent International.

Chinese e-commerce company Baozun Inc filed with U.S. regulators for an initial public offering of American Depository Shares, becoming the second e-commerce firm from the country that has filed to list in the United States this year, Reuters reported.